A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline

Not Applicable

Completed

Brief Summary: The study is to understand whether distribution of two different supplies of nicotine patches through a telephone quitline has an effect on quit rates. The two different supplies are four vs. eight (in two separate four-week mailings) weeks of nicotine patches. The hypothesis is that eight weeks will be slightly more efficacious but four weeks will be more cost-effective.

Recruitment & Eligibility

Inclusion Criteria

All callers to the Colorado QuitLine who report currently smoking 16-20 cigarettes
who enroll in QuitLine services
who do not require physician approval to obtain nicotine replacement therapy
who are willing to receive the nicotine patch

Exclusion Criteria

Contraindications to receiving the nicotine patch through the QuitLine without physician approval include: history of hearth disease (heart attack, chest pain, or coronary artery disease), high blood pressure, pregnancy, skin conditions such as difficult to manage psoriasis or eczema, or history of a local reaction to the nicotine patch
those who do not complete the call in English

Arm && Interventions

Group	Intervention	Description
Nicotine Patch (4 weeks)	Nicotine Patch	participants receive one 4-weeks supply of nicotine patches
Nicotine Patch (8 weeks)	Nicotine Patch	participants receive up to 8 weeks of nicotine patches in up to two 4-week supplies

Primary Outcome Measures

Name	Time	Method
7-day smoking abstinence	7 days
cost-effectiveness	6 months	cost per quit of each study arm will be calculated based on the total costs of the intervention from actual utilization data (nicotine patch costs + counseling call costs) and quit rates
6-month smoking abstinence	6 months

Secondary Outcome Measures

Name	Time	Method

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial